Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001619856-25-000043
Filing Date
2025-05-08
Accepted
2025-05-08 16:19:26
Documents
84
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q crbu-20250331.htm   iXBRL 10-Q 936273
2 EX-10.2 crbu-20250331xex102x2025x0.htm EX-10.2 43718
3 EX-31.1 crbu-20250331xexx311.htm EX-31.1 10538
4 EX-31.2 crbu-20250331xexx312.htm EX-31.2 10591
5 EX-32.1 crbu-20250331xexx321.htm EX-32.1 4910
6 EX-32.2 crbu-20250331xexx322.htm EX-32.2 4958
  Complete submission text file 0001619856-25-000043.txt   6608068

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT crbu-20250331.xsd EX-101.SCH 49177
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT crbu-20250331_cal.xml EX-101.CAL 64776
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT crbu-20250331_def.xml EX-101.DEF 234601
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT crbu-20250331_lab.xml EX-101.LAB 654407
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT crbu-20250331_pre.xml EX-101.PRE 466317
87 EXTRACTED XBRL INSTANCE DOCUMENT crbu-20250331_htm.xml XML 882043
Mailing Address 2929 7TH STREET, SUITE 105 BERKELEY CA 94710
Business Address 2929 7TH STREET, SUITE 105 BERKELEY CA 94710 510-982-6030
Caribou Biosciences, Inc. (Filer) CIK: 0001619856 (see all company filings)

EIN.: 453728228 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40631 | Film No.: 25926480
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)